交易 Axogen Inc - AXGN
Axogen Inc. (NASDAQ: AXGN) develops and markets technologies for peripheral nerve repair, offering solutions that restore function and quality of life for patients with nerve injuries. Its portfolio includes nerve grafts, connectors, and wraps that support surgeons in reconstructive and trauma procedures. Axogen’s shares move with surgical adoption rates, reimbursement developments, and clinical results supporting broader use of its products.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


